DK1123937T3 - Substans GM-95, fremgangsmåde til dets fremstilling samt anvendelse deraf - Google Patents

Substans GM-95, fremgangsmåde til dets fremstilling samt anvendelse deraf

Info

Publication number
DK1123937T3
DK1123937T3 DK99949337T DK99949337T DK1123937T3 DK 1123937 T3 DK1123937 T3 DK 1123937T3 DK 99949337 T DK99949337 T DK 99949337T DK 99949337 T DK99949337 T DK 99949337T DK 1123937 T3 DK1123937 T3 DK 1123937T3
Authority
DK
Denmark
Prior art keywords
compound
medicine
substance
preparation
chem
Prior art date
Application number
DK99949337T
Other languages
English (en)
Inventor
Haruo Seto
Kazuo Shin-Ya
Konstanty Wierzba
Original Assignee
Sosei Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sosei Co Ltd filed Critical Sosei Co Ltd
Application granted granted Critical
Publication of DK1123937T3 publication Critical patent/DK1123937T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/185—Heterocyclic compounds containing sulfur atoms as ring hetero atoms in the condensed system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK99949337T 1998-10-23 1999-10-20 Substans GM-95, fremgangsmåde til dets fremstilling samt anvendelse deraf DK1123937T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP30263498 1998-10-23

Publications (1)

Publication Number Publication Date
DK1123937T3 true DK1123937T3 (da) 2004-10-11

Family

ID=17911355

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99949337T DK1123937T3 (da) 1998-10-23 1999-10-20 Substans GM-95, fremgangsmåde til dets fremstilling samt anvendelse deraf

Country Status (11)

Country Link
US (2) US6613759B1 (da)
EP (1) EP1123937B1 (da)
KR (1) KR100446323B1 (da)
AT (1) ATE267832T1 (da)
AU (1) AU770166B2 (da)
CA (1) CA2346201C (da)
DE (1) DE69917668T2 (da)
DK (1) DK1123937T3 (da)
ES (1) ES2217815T3 (da)
PT (1) PT1123937E (da)
WO (1) WO2000024747A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1350794B1 (en) 2000-12-12 2005-06-22 Sosei Co., Ltd. Process for preparing substance gm-95
US7045523B2 (en) 2001-10-18 2006-05-16 Novartis Ag Combination comprising N-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidine-amine and telomerase inhibitor
WO2004074295A1 (ja) * 2003-02-21 2004-09-02 Keio University チアゾール環状多量体、その製造方法、その合成中間体およびその利用
CA2517850A1 (en) * 2003-03-04 2004-09-16 Sosei Co., Ltd. Gm-95-containing antitumor effect potentiator, combined antitumor preparation and antitumor agent
JP2006160723A (ja) * 2004-11-10 2006-06-22 Marine Biotechnol Inst Co Ltd 抗腫瘍活性を有する化合物及びその製造方法
CA2663807C (en) * 2006-10-30 2018-05-01 E.I. Du Pont De Nemours And Company .delta.17 desaturase and its use in making polyunsaturated fatty acids
DE102014205356A1 (de) * 2014-03-21 2015-09-24 Robert Bosch Gmbh Elektrode für eine Lithium-Zelle
CN110283762B (zh) * 2019-08-01 2020-09-22 哈尔滨天齐人类第二基因组技术开发应用科技有限责任公司 一株具有强力抗癌活性的链霉菌ccpm7649及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1061482B (de) * 1958-04-29 1959-07-16 R I T Rech Et Ind Therapeutiqu Verfahren zur Reinigung des Antibiotikums 899
DE3783218T2 (de) 1986-11-21 1993-06-03 Merck & Co Inc Fermentationsanaloge von virginiamycin-m1.
US5434260A (en) 1992-10-13 1995-07-18 American Home Products Corporation Carbamates of rapamycin
ATE206125T1 (de) * 1996-12-18 2001-10-15 Kyowa Hakko Kogyo Kk Furoindolizine
JPH11180997A (ja) 1997-12-24 1999-07-06 Yamanouchi Pharmaceut Co Ltd 新規抗腫瘍化合物

Also Published As

Publication number Publication date
EP1123937B1 (en) 2004-05-26
DE69917668D1 (de) 2004-07-01
US20030191165A1 (en) 2003-10-09
DE69917668T2 (de) 2005-05-19
US6613759B1 (en) 2003-09-02
CA2346201C (en) 2007-06-05
WO2000024747A1 (en) 2000-05-04
PT1123937E (pt) 2004-09-30
AU770166B2 (en) 2004-02-12
KR100446323B1 (ko) 2004-08-30
ES2217815T3 (es) 2004-11-01
EP1123937A9 (en) 2001-11-14
ATE267832T1 (de) 2004-06-15
CA2346201A1 (en) 2000-05-04
EP1123937A1 (en) 2001-08-16
US7192763B2 (en) 2007-03-20
AU6227799A (en) 2000-05-15
KR20010103610A (ko) 2001-11-23

Similar Documents

Publication Publication Date Title
NO893021D0 (no) Fremgangsmaate for fremstilling av en biologisk aktiv forbindelse, fr 901228.
NZ337861A (en) N-heterocyclic derivatives for treating multiple sclerosis, HIV dementia, Parkinson's disease, meningitis, atherosclerosis, cancer, inflammatory skin diseases
UA42734C2 (uk) Водорозчинна сіль німеcуліду, водний розчин солі німеcуліду, композиції на основі німеcуліду, спосіб отримання водорозчинної солі німеcуліду та фармацевтична композиція для лікування запалювальних захворювань
HUT43843A (en) Process for production of derivatives of benzimidasole and medical compounds containing thereof
SG103194G (en) Pharmaceutical composition containing a tetrapyrrole compound as active ingredient and process for the production of the tetrapyrrole compound
ES555147A0 (es) Un procedimiento para la produccion de un compuesto de tiazolidindiona hipoglicemico
HUT67039A (en) Process for preparing 2-substituted saccharin derivatives and pharmaceutical compositions containing them
HUT61777A (en) Process for producing pyrimidine-nukleozides and pharmaceutical compositions containing them as active components
FI95773B (fi) Menetelmä vesipitoisen, N-(3,4-dimetoksikinnamoyyli)antraniilihappoa sisältävän farmaseuttisen koostumuksen valmistamiseksi
EP0902022A4 (en) NOVEL BENZOFURANONE DERIVATIVES AND PROCESS FOR THE PRODUCTION THEREOF
AU667593B2 (en) Inhibitors of HIV protease useful for the treatment of AIDS
NO173444C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 4-(4'- fluorfenyl-)-tienopyridin-derivater
HUT46536A (en) Process for producing antianxietive pharmaceutical compositions
DE69011913D1 (de) Phthalinidderivat, pharmazeutische Zubereitung und Verwendung.
DK1123937T3 (da) Substans GM-95, fremgangsmåde til dets fremstilling samt anvendelse deraf
AU7266291A (en) A novel substituted-amine compound and a process for the preparation thereof
AU695190B2 (en) Substance FA-70D, process for producing the same, and uses thereof
FR2775976B1 (fr) Composition pharmaceutique ou cosmetique contenant un precurseur d'actif hydrolysable par la glucocerebrosidase
NO20031137D0 (no) Fremgangsmåte for fremstilling av kirale forbindelser
HUT47020A (en) Process for production of stabilly injectable medical compounds containing as active substance 1,4-dihidroxi-5,8-bis/2/2-hidroxi-ethil-amin/-ethil-amin-antraquinon-dihydrochlorid
EP0721985A4 (en) THE SUBSTANCE IT-62-B AND MEDICAL PREPARATIONS CONTAINING IT